期刊文献+

溴甲纳曲酮有关物质的HPLC-MS分析 被引量:1

HPLC-MS Analysis of Related Substance in Methylnaltrexone Bromide
下载PDF
导出
摘要 目的:建立梯度洗脱反相高效液相色谱法测定溴甲纳曲酮中的有关物质。方法:采用高效液相色谱法,色谱柱为Shim-pack CLC-ODS(4.6 mm×150 mm,5μm),以甲醇-水-三氟乙酸(5:95:0.1)为流动相A,以甲醇-水-三氟乙酸(65:35:0.1)为流动相B,以1.0 mL.min-1的流速进行梯度洗脱,进样量20μL,检测波长230 nm。电喷雾电离源(ESI),电离源电压4.0 kV,喷雾气氮气的流速为9.0 L.min-1,干燥气温度为325℃,柱后分流;质谱扫描质量范围m/z 100~1000。结果:各有关物质与主成分均达到基线分离,分析了溴甲纳曲酮粗品中的杂质可能结构。结论:本法灵敏、专属,能有效分离降解产物及有关物质,可用于有关物质及降解产物检查。 Objective: To establish an HPLC method to analyze the related substance of methylnahrexone bromide. Methods: The HPLC on Shim-pack The mobile phase consisted of a mixture of CLC-ODS column (4.6mm×150mm,5μm) was adopted; methanol-water-TFA (5:95:0.1) as mobile phase A and a mixture of methanol-water-TFA (65:35:0.1) as mobile phase B. Gradient elution was used. The flow rate was 1.0 mL·min^-1, the wavelength was set at 230 nm. Eletrospray ionization mass spectrum was applied, the spray capillary voltage was 4.0 kV, flow rate of dry gas N2 was 9.0 L·min^-1, the dry gas temperature was set at 325 ℃, and the scan range was m/z 100-1000. Results: The structures of impurities appeared in rough product (methylnaltrexone bromide) were analyzed. Conclusion: The method was proved to be sensitive and selective for the separation of methylnaltrexone bromide, impurities and degradation products.
作者 杨琼瑶 李赟
出处 《药学与临床研究》 2011年第4期374-376,共3页 Pharmaceutical and Clinical Research
关键词 溴甲纳曲酮 有关物质 高效液相色谱-质谱联用 Methylnaltrexone bromide Related substance HPLC-MS
  • 相关文献

参考文献5

  • 1U.S.FDA.FDA approves relistor for opioid-induced constipation: Drug will help reduce effects of drugs like morphine on bowel function [EB/OL]. (2008-04-24) [2009 -06 -18]. http://www.fda.gov/NewsEvents/Newsroom/ Press Announcements/2008/ucm116885.htm.
  • 2任健,程卯生.溴化甲基纳曲酮(methylnaltrexone bromide)[J].中国药物化学杂志,2008,18(5):400-400. 被引量:2
  • 3Russell J, Bass P, Goldberg LI, et al.Antagonism of gut, but not central effects of morphine with quaternary narcotic antagonists[J]. Eur J Pharmacol, 1982, 78(3): 255-61.
  • 4Chen T Y, Rosow C E,Serradell N, et al. Methylnaltrexone bromide: opioid receptor antagonist treatment of constipation treatment of postoperative ileus [J]. Drugs Future, 2007, 32(9): 771-5.
  • 5普罗热尼奇制药公司.(R)-N-甲基纳曲酮、其合成方法以及其药物用途:中国,200680022957.X[P].2006-05-25.

二级参考文献4

  • 1RUSSELL J, BASS P, GOLDBERG L I, et al. Antagonism of gut, but not central effects of morphine with quaternary narcotic antagonists[J]. Eur J Pharmacol, 1982, 78(3) :255 - 261.
  • 2CHEN T-Y, ROSOW C E, SERRADELL N, et al. Methylnaltrexone bromide:opioid receptor antagonist treatment of constipation treatment of postoperative ileus [ J ]. Drugs Future, 2007, 32(9) :771 - 775.
  • 3RxList Inc. Relistor indication and dosage [ EB/OL ]. [ 2008 - 06- 16 ]. URL: http://www. rxlist. com/cgi/generic/relistor. htm.
  • 4LEON I, HERBERT M, KLAUS S. Quaternary derivatives of noroxymorphone which relieve intestinal immobility: US, 4176186[P]. 1979 - 11 - 27.

共引文献1

同被引文献8

  • 1U.S. FDA approves relistor for opioid-induced constipation; Drug will help reduce effects of drugs like morphine on bowel function [EB/OL]. (2008-04-24). http://www.fda. gov/ewsEvents/newsroom/PressAnnouncements/2008/ucm 116885.htm.
  • 2Liu Z, Tang L, Zou P, et al. Synthesis and biological evaluation of allylated and prenylated mono-carbonyl analogs of curcumin as anti-inflammatory agents[J].Eur J Med Chem, 2014, 74: 671-682.
  • 3Finlay B B, McFadden G. Anti-immunology: evasion of the host immune system by bacterial and viral pathogens[J].Cell, 2006, 124(4): 767-782.
  • 4Chen T Y, Rosow C E, Serradel N, et al. Methylnaltrexone bromide: opioid receptor antagonist treatment of constipation treatment of postoperative ileus[J].Drug future, 2007, 32(9): 771-775.
  • 5赛诺菲–安万特. 制备N-烷基纳曲酮卤化物的方法 [P]. 中国: 102225939A, 2009-08-26.
  • 6Peter W X, Cantrell G L, Halvachs R E, et al. Halvach process for the preparation of quaternary n-alkyl morphinan alkaloid salts [P]. WO: 2004043964, 2014-03-11.
  • 7Nataliya B, Donato G J, Fabian S R, et al. Peripheral opioid receptor antagonists and uses thereof [P]. WO: 20102676881, 2013-04-16.
  • 8Hudlicky T, Carroll R, Leisch H, et al. Processes for the preparation of morphinane and morphinone compounds [P]. WO: 2010121369, 2010-10-28.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部